Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Effect by GLP-1 Level in Prediabetes and T2DM
NCT05290506Phase 3Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Aug 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM), prediabetes, sponsored by Universiti Kebangsaan Malaysia. Started Aug 2020; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)prediabetes
Beyond the preview
Go deeper on NCT05290506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05290506.